Epkinly (pTAP negotiation) (epcoritamab)

pCPA File Number: 22708
Negotiation Status:
Active Negotiation
Indication(s):
For the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma not otherwise specified (DLBCL NOS), DLBCL transformed from indolent lymphoma, high grade B-cell lymphoma (HGBCL), primary mediastinal B-cell lymphoma (PMBCL) or follicular lymphoma Grade 3B (FLG3b) after two or more lines of systemic therapy and who have previously received or are unable to receive CAR-T cell therapy.
Sponsor/Manufacturer:
AbbVie Corporation
CDA-AMC Project Number:
PC0334-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable